Pacific Biosciences Raises $100M in Series E Financing; Plans to Commercialize Sequencer in 2010 | GenomeWeb
NEW YORK (GenomeWeb News) - Pacific Biosciences said today that it has raised $100 million in new financing that it will use to commercially develop its single-molecule DNA sequencing platform.
Hugh Martin, chairman and CEO of Pacific Biosciences, said in a statement that the financing “will enable us to surge forward with an aggressive development program” and commercialize the platform in 2010.
 
The Series E private equity funding came from a group composed of both new previous investors.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.